Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular Events in Community Population(PICC Study)

Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular and Cerebrovascular Events in Community Population(PICC Study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04212520

Enrollment

6500

Registered

2019-12-27

Start date

2020-01-01

Completion date

2050-12-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid

Keywords

non-fasting lipid, cardiovascular and cerebrovascular events, major adverse cardiovascular events

Brief summary

Numerous studies have shown that non-fasting blood lipid levels are closely related to the occurrence of cardiovascular and cerebrovascular events, but it is still unclear in the Chinese population. The purpose of the study is to investigate the association between non-fasting blood lipid levels and adverse outcomes in Chinese community population.

Detailed description

Study population includes subjects who living in community, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide biological sample at one or more study visits. Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

•≥18 years old; * Signed informed consent; * Life expectancy is greater than 1 year.

Exclusion criteria

* mental disorder; * is not willing to participate in the clinical study; * suffered with other disease to quite the trial; * violated the protocol.

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality	Through study completion, an average of 1 years	All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.
Cardiovascular Mortality	Through study completion, an average of 1 years	Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).
Cardiovascular and cerebrovascular diseases	Through study completion, an average of 1 years	The number of and the incidence rate of cardiovascular and cerebrovascular diseases.

Countries

China

Contacts

Primary ContactFeng Ying-qing, PhD

651792209@qq.com+862083827812

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026